Combo Therapy May Improve HbA1c in Type 2 Diabetes - Poll - MDSpire

Combo Therapy May Improve HbA1c in Type 2 Diabetes

Oral orforglipron could be more effective in reducing hemoglobin A1c and body weight, with no increased risk of hypoglycemia in patients with inadequately controlled type 2 diabetes.

  • By

  • Andrea Surnit

  • June 12, 2026

  • 4 min

Share

Original Source(s)

Combo Therapy May Improve HbA1c in Type 2 Diabetes

  • by Andrea Surnit

  • June 12, 2026

Related Content

Sleep Study Cutoffs May Guide Discharge

Preoperative sleep study values may distinguish lower-risk children within a population for whom overnight admission is currently routine.

Insulin-like growth factor binding proteins in metabolic dysfunction-associated steatotic liver disease

Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial